Artificial Intelligence (AI) has huge potential to shape healthcare for the better. However, it also creates ethical and legal challenges that we will discuss in this seminar. How do we ensure that AI technologies are safe and effective? What are the risks of black-box precision medicine? Who will be liable in the case of an incorrect treatment recommendation by an AI? How do we adequately protect health-related data? What is the impact of AI globally?
In this seminar, Professor Cohen and Ms. Gerke will not only address these questions, but will also provide an overview of the meaning of AI and its current and future application in healthcare.
Lunch will be provided.
Click here or on the flyer below to register.
I. Glenn Cohen (@CohenProf) is the James A. Attwood and Leslie Williams Professor of Law at Harvard Law School and current Faculty Director of the Petrie-Flom Center. A member of the inaugural cohort of Petrie-Flom Academic Fellows, Glenn was appointed to the Harvard Law School faculty in 2008. Glenn is one of the world's leading experts on the intersection of bioethics (sometimes also called "medical ethics") and the law, as well as health law. He is the author of more than 70 articles and chapters and his award-winning work has appeared in leading legal (including the Stanford, Cornell, and Southern California Law Reviews), medical (including the New England Journal of Medicine, JAMA), bioethics (including the American Journal of Bioethics, the Hastings Center Report) and public health (the American Journal of Public Health) journals, as well as Op-Eds in the New York Times and Washington Post.
Sara Gerke (@gerke_sara) joined the Petrie-Flom Center's Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL) in August 2018. Before joining the Petrie-Flom Center, Sara was employed as General Manager of the Institute for German, European and International Medical Law, Public Health Law and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) in Germany. She was also the Co‑Investigator of an interdisciplinary project, known as “ClinhiPS”, sponsored by the German Federal Ministry of Education and Research. This project analyzed the clinical application of human induced pluripotent stem cells (hiPSCs) in Germany and Austria from a scientific, ethical and comparative legal perspective. She holds an MA in Medical Ethics & Law from King’s College London and is currently completing her PhD.